Clinical Trials
30 trialsNCT06279143 2026-05-26
dOCT-pBCC
Vejle Hospital
Completed
NCT06240741 2026-02-03
A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
Novartis
Phase 3 Completed
NCT03598426 2025-09-03
Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity
Loma Linda University
Phase 3 Completed
NCT04761822 2025-08-12
SARS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT01837693 2025-06-26
NTCC2
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT01673906 2025-06-24
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT06039137 2024-09-25
H1-Switch
Erasmus Medical Center
Completed
NCT02835625 2024-08-28
TOBE
Norwegian Institute of Public Health
Phase NA Completed
NCT03917147 2023-04-12
Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination
University of Campania Luigi Vanvitelli
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT00831571 2022-04-18
Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
Dana-Farber Cancer Institute
Completed
NCT04907422 2021-09-01
Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours
October 6 University
Completed
NCT03270215 2020-12-17
The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion
Naestved Hospital
Completed
NCT03272997 2020-12-17
The Value of PET-CT in Pleural Effusions
Naestved Hospital
Completed
NCT02349763 2020-10-23
DEPARO
Department of Medical Services Ministry of Public Health of Thailand
Phase 3 Completed
NCT03847753 2020-05-22
COMO-GMC
University of Aarhus
Completed
NCT03406325 2020-04-09
Mast Cell Activation Test in Allergic Disease
Hong Kong Sanatorium & Hospital
Completed
NCT01091545 2019-11-13
MBTST
Region Skane
Phase NA Completed
NCT03858738 2019-03-04
A Pilot Study on Use of Liquid Crystal Contact Thermography to Detect Early Breast Cancer
Braster S.A.
Completed
NCT01663753 2019-01-07
ERRICC
Hospices Civils de Lyon
Phase NA Completed
NCT01206777 2017-12-20
Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT02829021 2016-07-12
Dynamic Infrared Thermography in Breast Cancer Diagnostics
University Hospital of North Norway
Phase NA Completed
NCT01033123 2016-03-17
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Sanofi
Phase 2 Completed
NCT01033292 2016-03-17
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Sanofi
Phase 2 Completed
NCT01658280 2016-02-03
Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Phase 4 Completed
NCT01436617 2013-03-08
IgES
Centre Francois Baclesse
Completed
NCT00116610 2009-01-21
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
Poniard Pharmaceuticals
Phase 2 Completed